These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826 [TBL] [Abstract][Full Text] [Related]
43. Clinical Impact of Vancomycin Treatment in Ampicillin-Susceptible Enterococci Bloodstream Infections. Hemapanpairoa J; Changpradub D; Santimaleeworagun W Antibiotics (Basel); 2022 Nov; 11(12):. PubMed ID: 36551355 [TBL] [Abstract][Full Text] [Related]
44. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. Smith JR; Barber KE; Raut A; Aboutaleb M; Sakoulas G; Rybak MJ J Antimicrob Chemother; 2015; 70(6):1738-43. PubMed ID: 25645208 [TBL] [Abstract][Full Text] [Related]
45. Treatment of vancomycin-resistant enterococcus with quinupristin/dalfopristin and high-dose ampicillin. Bethea JA; Walko CM; Targos PA Ann Pharmacother; 2004 Jun; 38(6):989-91. PubMed ID: 15100393 [TBL] [Abstract][Full Text] [Related]
46. Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review. Marino A; Munafò A; Zagami A; Ceccarelli M; Campanella E; Cosentino F; Moscatt V; Cantarella G; Di Mauro R; Bernardini R; Nunnari G; Cacopardo B IDCases; 2022; 28():e01462. PubMed ID: 35265458 [TBL] [Abstract][Full Text] [Related]
47. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM; Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215 [TBL] [Abstract][Full Text] [Related]
48. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis. Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM; J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495 [TBL] [Abstract][Full Text] [Related]
49. Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children. Ibrahim SL; Zhang L; Brady TM; Hsu AJ; Cosgrove SE; Tamma PD Clin Infect Dis; 2015 Oct; 61(7):1119-24. PubMed ID: 26082503 [TBL] [Abstract][Full Text] [Related]
51. Isolation, characterization, and comparative genomic analysis of a phage infecting high-level aminoglycoside-resistant (HLAR) Nasr Azadani D; Zhang D; Hatherill JR; Silva D; Turner JW PeerJ; 2020; 8():e9171. PubMed ID: 32509458 [No Abstract] [Full Text] [Related]
52. In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci. Wu T; Meyer K; Harrington AT; Danziger LH; Wenzler E J Antimicrob Chemother; 2019 May; 74(5):1300-1305. PubMed ID: 30753495 [TBL] [Abstract][Full Text] [Related]
53. Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci. Antony SJ; Matherin P; Stratton C Scand J Infect Dis; 1995; 27(4):401-3. PubMed ID: 8658079 [TBL] [Abstract][Full Text] [Related]
54. Characterization of aminoglycoside resistance and virulence genes among Enterococcus spp. isolated from a hospital in China. Li W; Li J; Wei Q; Hu Q; Lin X; Chen M; Ye R; Lv H Int J Environ Res Public Health; 2015 Mar; 12(3):3014-25. PubMed ID: 25768240 [TBL] [Abstract][Full Text] [Related]
55. [Enterococcal infections. Clinical findings and treatment considering antibiotic resistance in Denmark]. Olesen HV; Møller JK Ugeskr Laeger; 2002 Apr; 164(18):2386-90. PubMed ID: 12024841 [TBL] [Abstract][Full Text] [Related]
56. Successful clearance of catheter-related bloodstream infection by antibiotic lock therapy using ampicillin. Elwood RL; Spencer SE Ann Pharmacother; 2006 Feb; 40(2):347-50. PubMed ID: 16449537 [TBL] [Abstract][Full Text] [Related]